01
Cash & equivalents increased 34.3%
Cash & equivalents changed +34.3% from the comparable as-filed period.
$13.5M→$18.1MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTIN8BIO, INC.'s latest supported as-filed period reports net income of -$4.8M, 6.1% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +34.3% from the comparable as-filed period.
Net income changed +6.1% from the comparable as-filed period.
Operating income changed +6.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
INAB · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-338012SEC ↗8-KAug 6, 2026Period Aug 6, 20260001193125-26-337944SEC ↗8-KJun 1, 2026Period May 29, 20260001193125-26-249684SEC ↗4May 29, 2026Period May 27, 20260001682638-26-000006SEC ↗4May 12, 2026Period May 9, 20260001830914-26-000004SEC ↗4May 12, 2026Period May 9, 20260001853815-26-000002SEC ↗4May 12, 2026Period May 9, 20260001830059-26-000004SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| May 27, 2026Filed May 29, 2026 | FAIRBAIRN EMILYDirector | GiftIndirect | 724,637 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -63.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001682638-26-000004